Literature DB >> 648076

Propranolol withdrawal and thyroid hormones in patients with essential hypertension.

B O Kristensen, E Steiness, J Weeke.   

Abstract

The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension. The patients had been treated from 2 to 18 mo before the study was begun. Doses varied from 160 to 480 mg propranolol daily. Four of the patients studied developed tachycardia, sweating, or tremor within 2 to 6 days after withdrawal of propranolol. In 1 patient reversible ischemic ECG changes were recorded. The serum concentrations of free T3 increased in the 4 patients suffering from withdrawal symptoms. The mean increase on the day the symptoms started was 51% (range, 22 to 74, 2 p = 0.01). This increase in serum-free T3 correlated positively with the serum propranolol concentration on the last day propranolol was given (r = 0.91, 2 p = 0.03). In the one patient, who did not develop withdrawal symptoms, the serum concentration of propranolol was very low, and the free T3 level remained unchanged. No significant changes in serum concentrations of free T4 or total thyroid hormones were found in any of the patients. We suggest that the propranolol withdrawal symptoms are, at least partially, caused by an increase in the thyroid hormone, T3.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648076     DOI: 10.1002/cpt1978236624

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.

Authors:  O Lederballe Pedersen; E Mikkelsen; J Lanng Nielsen; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

2.  Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.

Authors:  J H Botting; P Crook
Journal:  Experientia       Date:  1981-12-15

Review 3.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.

Authors:  R J Walden; P Bhattacharjee; B Tomlinson; J Cashin; B R Graham; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 5.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

6.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.

Authors:  R D Aarons; A S Nies; J Gal; L R Hegstrand; P B Molinoff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

Review 7.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Drug withdrawal syndromes-- a literature review.

Authors:  G C Hodding; M Jann; I P Ackerman
Journal:  West J Med       Date:  1980-11

Review 9.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 10.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.